Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

NCT02723721

Conditions: Hutchinson's Melanotic Freckle, Lentigo Maligna, Melanoma, +7 more
Locations: AP-HP Hopital Avicenne Bobigny, France

AP-HP Hôpital Ambroise Paré Boulogne-Billancourt, France

Hôpital du Morvan Brest, France

CHRU de Lille Lille, France

View Trial Details

Completed

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

NCT03276832

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +13 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

NCT04960059

Conditions: Adenocarcinoma, Bronchial Neoplasms, Cancer, +34 more
Locations: The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Study of DF6215 in Patients With Advanced Solid Tumors

NCT06108479

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations: The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States

University of California Irvine Medical Center Orange, California, United States

University of California San Diego Moores Cancer Center San Diego, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

View all 21 locations

View Trial Details

Completed

A Study of DF6002 Alone and in Combination With Nivolumab

NCT04423029

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations: University of California Irvine Orange, California, United States

SCRI - HealthOne Denver Denver, Colorado, United States

Yale School of Medicine New Haven, Connecticut, United States

University of Miami Miami, Florida, United States

View all 32 locations

View Trial Details

Completed

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

NCT03070392

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: UCLA Medical Center Los Angeles, California, United States

The Angeles Clinic and Research Institute Los Angeles, California, United States

Byers Eye Institute, Stanford University Palo Alto, California, United States

California Pacific Medical Center San Francisco, California, United States

View all 57 locations

View Trial Details

Completed

AI-based Medical Device Validation for Early Melanoma Detection

NCT06221397

Conditions: Disease, Melanoma, Melanoma, Skin, +13 more
Locations: University Hospital of Cruces Barakaldo, Biscay, Spain

View Trial Details

Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States

NEXT Oncology ( Site 0300) San Antonio, Texas, United States

Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada

View Trial Details

Completed

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

NCT01046487

Conditions: Adenocarcinoma, Cancer, Carcinoma, +30 more
Locations: Institut Bergonié Bordeaux, France

Centre Oscar Lambret Lille, France

Centre Léon Bérard Lyon, France

View Trial Details

Completed

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT04283669

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: The University of Alabama at Birmingham (Site 700) Birmingham, Alabama, United States

Univ of California @ Los Angeles (Site 325) Los Angeles, California, United States

Children's National Medical Center (Site 775) Washington D.C., District of Columbia, United States

Children's HealthCare of Atlanta (Site 950) Atlanta, Georgia, United States

View all 15 locations

View Trial Details